EMA’s CHMP Is Set To Adopt Position On Another Avastin Biosimilar

Two EC Approvals, One Positive Opinion So Far

 
• By Dean Rudge
  
Crossroad
The CHMP may adopt an opinion on another bevacizumab filing • Source: Shutterstock

More from Biosimilars

More from Products